Bristol’s new myeloma CAR-T needs a hefty discount to be cost-effective, watchdogs say while endorsing GSK’s Blenrep April 7, 2021 Auto Bot News 0 Bristol’s new myeloma CAR-T needs a hefty discount to be cost-effective, watchdogs say while endorsing GSK’s Blenrep esagonowsky Wed, 04/07/2021 – 09:45
